RecruitingNCT06449404

7.0T Magnetic Resonance Imaging Study of Parkinson's Disease


Sponsor

Chinese PLA General Hospital

Enrollment

200 participants

Start Date

Mar 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This clinical trial study is conducted to detect the imaging characteristics of the patients with Parkinson's diseases (PD) by 7-Tesla (7T) magnetic resonance imaging (MRI).


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study uses ultra-high-field 7 Tesla MRI — a more powerful brain imaging tool than standard MRI — to study Parkinson's disease in detail. The goal is to identify new imaging markers that could improve diagnosis and understanding of how Parkinson's affects the brain. **You may be eligible if...** - You have been diagnosed with Parkinson's disease by a specialist neurologist **You may NOT be eligible if...** - You have other brain conditions such as cerebrovascular disease, brain tumors, or epilepsy - You have psychiatric disorders affecting cognition - You have anything in your body that prevents you from having an MRI (such as a pacemaker or certain metal implants) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHER7T-MRI scaning

7T-MRI scaning


Locations(1)

Chinese PLA General Hospital

Beijing, Beijing, China, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06449404


Related Trials